These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25922551)

  • 1. Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress.
    Tomandlova M; Jarkovsky J; Tomandl J; Kubkova L; Kala P; Littnerova S; Gottwaldova J; Kubena P; Ganovska E; Poloczek M; Spinar J; Mueller C; Mebazaa A; Pavkova Goldbergova M; Parenica J
    Dis Markers; 2015; 2015():159051. PubMed ID: 25922551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention.
    Guo R; Li Y; Wen J; Li W; Xu Y
    Cardiology; 2014; 129(3):178-88. PubMed ID: 25323314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
    Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
    Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Akgul O; Baycan OF; Bulut U; Somuncu MU; Pusuroglu H; Ozyilmaz S; Gul M; Demir AR; Yılmaz E; Yazan S; Kokturk U; Cetin I; Uyarel H
    Coron Artery Dis; 2015 Nov; 26(7):592-7. PubMed ID: 26061437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides, nitrite/nitrate and superoxide dismutase have additional value on top of the GRACE score in prediction of one-year mortality and rehospitalisation for heart failure in STEMI patients - Multiple biomarkers prospective cohort study.
    Parenica J; Kala P; Pavkova MG; Tomandl J; Spinar J; Littnerova S; Jarkovsky J; Mebazaa A; Tomandlova M; Dastych M; Gottwaldova J; Gayat E
    Int J Cardiol; 2016 May; 211():96-104. PubMed ID: 26991556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction.
    Matsui S; Ishii J; Kitagawa F; Kuno A; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Tanaka I; Nomura M; Hishida H; Ozaki Y
    Atherosclerosis; 2010 May; 210(1):220-5. PubMed ID: 19945702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.
    Altay S; Çakmak HA; Kemaloğlu Öz T; Özpamuk Karadeniz F; Türer A; Erer HB; Kılıç GF; Keleş İ; Can G; Eren M
    Anatol J Cardiol; 2017 Mar; 17(3):202-209. PubMed ID: 27488759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction.
    Matsubara J; Sugiyama S; Nozaki T; Akiyama E; Matsuzawa Y; Kurokawa H; Maeda H; Fujisue K; Sugamura K; Yamamoto E; Matsui K; Jinnouchi H; Ogawa H
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25012287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
    Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
    Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of elevated systemic pentraxin-3 levels with high-risk coronary plaque components and impaired myocardial perfusion after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction.
    Kimura S; Inagaki H; Haraguchi G; Sugiyama T; Miyazaki T; Hatano Y; Yoshikawa S; Ashikaga T; Isobe M
    Circ J; 2014; 78(1):159-69. PubMed ID: 24132243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
    Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
    Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
    J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Stress and Inflammatory Markers PTX3, CypA, and HB-EGF: How Are They Linked in Patients With STEMI?
    Dejanović VV; Stevuljević JK; Vukašinović A; Miljković M; Kafedzic S; Zdravković M; Ilić I; Hinić S; Cerović M; Stefanović M; Spasojević-Kalimanovska V; Memon L; Nešković AN; Bogavac-Stanojević N
    Angiology; 2020 Sep; 71(8):713-720. PubMed ID: 32372694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma pentraxin 3 concentration with angiographic and clinical outcomes in patients with acute ST-segment elevation myocardial infarction treated by primary angioplasty.
    Dharma S; Sari NY; Santoso A; Sukmawan R; Rao SV
    Catheter Cardiovasc Interv; 2020 Nov; 96(6):1233-1239. PubMed ID: 31782880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study.
    George M; Shanmugam E; Srivatsan V; Vasanth K; Ramraj B; Rajaram M; Jena A; Sridhar A; Chaudhury M; Kaliappan I
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):275-84. PubMed ID: 25814534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
    Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
    Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sodium intake adversely affects oxidative-inflammatory response, cardiac remodelling and mortality after myocardial infarction.
    Costa AP; de Paula RC; Carvalho GF; Araújo JP; Andrade JM; de Almeida OL; de Faria EC; Freitas WM; Coelho OR; Ramires JA; Quinaglia e Silva JC; Sposito AC;
    Atherosclerosis; 2012 May; 222(1):284-91. PubMed ID: 22436606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.